Dan L. Hartman occupies the position of Scientific and Medical Advisory Board at Hopen Life Sciences LLC. Dr. Hartman is also on the board of Spexis Ltd. and EnBiotix, Inc. and Director-Integrated Development at Bill & Melinda Gates Foundation Trust.

Dr. Hartman previously occupied the position of Vice President-Worldwide Clinical Development at Esperion Therapeutics, Inc., Principal at Eli Lilly & Co., Executive Director & Principal at Pfizer Inc., Member of National Center for Advancing Translational Sciences, President & Chief Executive Officer for Great Lakes Drug Development, Inc., Senior Vice President-Product Development at deCODE genetics, Inc., President at The American Society for Clinical Pharmacology & Therapeutics and Chief Medical Resident at Indiana University.

Dan L. Hartman received a doctorate from Wayne State University (Michigan) and an undergraduate degree from Calvin College.